Patents by Inventor Jaro I. Karppinen

Jaro I. Karppinen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Osteoclast inhibitors such as zoledronic acid for low back pain treatment
    Patent number: 10092581
    Abstract: Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as Modic changes type 1.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: October 9, 2018
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Jaro I. Karppinen
  • OSTEOCLAST INHIBITORS SUCH AS ZOLEDRONIC ACID FOR LOW BACK PAIN TREATMENT
    Publication number: 20180161348
    Abstract: Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as Modic changes type 1.
    Type: Application
    Filed: January 24, 2018
    Publication date: June 14, 2018
    Inventors: Herriot Tabuteau, Jaro I. Karppinen
  • Osteoclast inhibitors such as zoledronic acid for low back pain treatment
    Patent number: 9943531
    Abstract: Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as Modic changes type I.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: April 17, 2018
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Jaro I. Karppinen
  • Osteoclast Inhibitors Such as Zoledronic Acid for Low Back Pain Treatment
    Publication number: 20170216324
    Abstract: Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as Modic changes type I.
    Type: Application
    Filed: April 11, 2017
    Publication date: August 3, 2017
    Inventors: Herriot Tabuteau, Jaro I. Karppinen
  • Osteoclast inhibitors such as zoledronic acid for low back pain treatment
    Patent number: 9623036
    Abstract: Methods for the safe administration of imidazole or imidazolium compounds, and conditions that may be treated by these methods, are described herein.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: April 18, 2017
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Jaro I. Karppinen
  • Osteoclast Inhibitors Such as Zoledronic Acid for Low Back Pain Treatment
    Publication number: 20160166589
    Abstract: Methods for the safe administration of imidazole or imidazolium compounds, and conditions that may be treated by these methods, are described herein.
    Type: Application
    Filed: January 28, 2016
    Publication date: June 16, 2016
    Inventors: Herriot Tabuteau, Jaro I. Karppinen
  • Osteoclast inhibitors such as zoledronic acid for low back pain treatment
    Patent number: 9289441
    Abstract: Methods for the safe administration of imidazole or imidazolium compounds, and conditions that may be treated by these methods, are described herein.
    Type: Grant
    Filed: March 4, 2015
    Date of Patent: March 22, 2016
    Assignee: ANTECIP BIOVENTURES II LLC
    Inventors: Herriot Tabuteau, Jaro I. Karppinen
  • Osteoclast Inhibitors Such As Zoledronic Acid For Low Back Pain Treatment
    Publication number: 20160038517
    Abstract: Methods for the safe administration of imidazole or imidazolium compounds, and conditions that may be treated by these methods, are described herein.
    Type: Application
    Filed: March 4, 2015
    Publication date: February 11, 2016
    Inventors: Herriot Tabuteau, Jaro I. Karppinen